My watch list
my.chemeurope.com  
Login  

02-06-2009: Agilent Technologies Inc. announced it has renamed Velocity11 as Agilent Automation Solutions. The company is also launching new products and applications designed to help researchers and scientists increase productivity and decrease costs. Agilent Automation Solutions is part of the Agilent's Life Sciences Solutions Unit. Agilent acquired Velocity11 in late 2007 and continues its focus on automating laboratory processes.

"Our name has changed, but our commitment to help our customers automate workflows has never been stronger," said Rob Nail, general manager, Agilent Automation Solutions Division. "Our revolutionary Direct Drive Robot and VWorks Automation Control Software enable scientists to focus on science, rather than the manual tasks that create significant inefficiencies in the lab."

Contact / Request information

Request further information free of charge:

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
More about Velocity11
  • News

    Agilent Technologies Introduces New Automation Brand

    Agilent Technologies Inc. announced it has renamed Velocity11 as Agilent Automation Solutions. The company is also launching new products and applications designed to help researchers and scientists increase productivity and decrease costs. Agilent Automation Solutions is part of the Agile ... more

    Agilent Technologies Signs Agreement to Acquire Velocity11

    Agilent Technologies Inc. and Velocity11 announced that they have signed a definitive agreement for Agilent to acquire Velocity11. Financial details were not disclosed. The acquisition is expected to be final in 30 to 60 days, subject to certain closing conditions. According to the company ... more

  • Companies

    Velocity11

    Velocity11 is a privately held company based in Menlo Park, Calif., and is focused on pioneering automation technology solutions for life science laboratories. The company’s customers comprise most of the major pharmaceutical and biotechnology companies as well as leading genome centers and ... more

Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE